A passive stake exceeds 5% at Whitehawk Therapeutics (WHWK), with two parties reporting the same shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Dellora Investments LP and its principal, Kevin Pyun, have each reported a 5.6% passive stake in Whitehawk Therapeutics (WHWK), amounting to 3,169,287 shares of common stock. Both parties hold shared voting and dispositive power over these shares but explicitly disclaim beneficial ownership under Rule 13d-4.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.